FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher Wood

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Antineoplastic Agents

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Surena F Matin; Janice N Cormier; Colin P N Dinney; Xuelin Huang; Louis L Pisters; Richard E Royal; John F Ward; Christopher G Wood; Curtis A Pettaway
Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma.
Patricia A Parker; Nizar Tannir; Diana L Urbauer; Christopher G Wood; Frances Alba; Bryan Fellman; Eric Jonasch; Jose A Karam; Yisheng Li; Surena F Matin
Illness Uncertainty and Quality of Life of Patients with Small Renal Tumors Undergoing Watchful Waiting: A 2-year Prospective Study.
Jose A Karam; Kamran Ahrar; Eric Jonasch; Priya Rao; Claudio A Romero; Nizar M Tannir; Raghunandan Vikram; Christopher G Wood; Surena F Matin
Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher Wood (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Surena F Matin; Janice N Cormier; Colin P N Dinney; Xuelin Huang; Louis L Pisters; Richard E Royal; John F Ward; Christopher G Wood; Curtis A Pettaway
Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma.
BJU international 2013;111(7):1068-74.
2013: Patricia A Parker; Nizar Tannir; Diana L Urbauer; Christopher G Wood; Frances Alba; Bryan Fellman; Eric Jonasch; Jose A Karam; Yisheng Li; Surena F Matin
Illness Uncertainty and Quality of Life of Patients with Small Renal Tumors Undergoing Watchful Waiting: A 2-year Prospective Study.
European urology 2013;63(6):1122-7.
2013: Jose A Karam; Kamran Ahrar; Eric Jonasch; Priya Rao; Claudio A Romero; Nizar M Tannir; Raghunandan Vikram; Christopher G Wood; Surena F Matin
Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results.
BJU international 2013;111(6):997-1005.
2013: Jose A Karam; Christopher G Wood
Words of wisdom: re: prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.
European urology 2013;63(4):769.
2013: Xiang Shu; Nizar M Tannir; Christopher G Wood; Jie Lin; Xifeng Wu
Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.
Journal of the National Cancer Institute 2013;105(6):424-32.
2012: Nizar M Tannir; Christopher G Wood; Lianchun Xiao; Ana Aparicio; John Araujo; Nebiyou B Bekele; Zita Lim; Surena Matin; Chaan Ng; Lance Pagliaro; Elizabeth Plimack; Lisa Smith; Pheroze Tamboli; Eric Jonasch
A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma.
European urology 2012;62(6):1013-9.
2012: E Jason Abel; Alonso Carrasco; Stephen Hembree Culp; Surena F Matin; Pheroze Tamboli; Nizar M Tannir; Christopher G Wood
Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
BJU international 2012;110(11):1742-6.
2012: Hubert H Chuang; Ferhat Deniz; Camilo Jimenez; Carlos Rubin De Celis; Kanishka Sircar; Christopher G Wood; Mouhammed Amir Habra
[¹⁸F]Fluorodeoxyglucose positron emission tomography-guided therapy in metastatic adrenocortical carcinoma: an illustrative case.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(26):e246-9.
2012: Patrick A Kenney; Christopher G Wood
Words of wisdom. Re: Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
European urology 2012;62(1):182-3.
2012: Jose A Karam; Christopher G Wood
The effects of temporary ischemia in partial nephrectomy on renal functional outcomes: how can effects best be estimated, and can they be mitigated?
European urology 2012;62(1):136-8; discussion 138-9.
2012: Patrick A Kenney; Christopher G Wood
Integration of surgery and systemic therapy for renal cell carcinoma.
The Urologic clinics of North America 2012;39(2):211-31, vii.
2012: Jose A Karam; Christopher G Wood
Management of small renal masses: watch, cut, freeze, or fry?
European urology 2012;61(5):905-6; discussion 906-7.
2012: Neema Navai; Christopher G Wood
Environmental and modifiable risk factors in renal cell carcinoma.
Urologic oncology 2012;30(2):220-4.
2012: Patricia A Parker; Louis L Pisters; Charles J Rosser; Richard Swartz; Diana Urbauer; Christopher G Wood; Bryan Fellman; Yisheng Li; Surena F Matin
Comprehensive assessment of quality of life and psychosocial adjustment in patients with renal tumors undergoing open, laparoscopic and nephron sparing surgery.
The Journal of urology 2012;187(3):822-6.
2011: Scott E Delacroix; Brian F Chapin; Christopher G Wood
The role of lymph node dissection in renal cell carcinoma.
The Urologic clinics of North America 2011;38(4):419-28, vi.
2011: Weiqi Tan; Christopher G Wood; Michelle A T Hildebrandt; Maosheng Huang; Jie Lin; Surena F Matin; Xia Pu; Pheroze Tamboli; Xifeng Wu
Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes.
The Journal of urology 2011;186(5):2071-7.
2011: Brian F Chapin; Stephen Hembree Culp; Scott E Delacroix; Eric Jonasch; Pheroze Tamboli; Nizar M Tannir; Graciela M Nogueras Gonzalez; Christopher G Wood
Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma.
European urology 2011;60(5):964-71.
2011: Scott E Delacroix; Surena F Matin; Graciela M Nogueras-Gonzalez; Pheroze Tamboli; Brian F Chapin; Jaclyn J Chen; Christopher G Wood
Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?
The Journal of urology 2011;186(4):1236-41.
2011: Jose A Karam; Christopher G Wood
The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
Hematology/oncology clinics of North America 2011;25(4):753-64.
2011: Brian F Chapin; Christopher G Wood
The RENAL nephrometry nomogram: statistically significant, but is it clinically relevant?
European urology 2011;60(2):249-51; discussion 251-2.
2011: Brian F Chapin; Scott E Delacroix; Christopher G Wood
Renal cell carcinoma: what the surgeon and treating physician need to know.
AJR. American journal of roentgenology 2011;196(6):1255-62.
2011: Brian F Chapin; Scott E Delacroix; Christopher G Wood
The role of lymph node dissection in renal cell carcinoma.
International journal of clinical oncology 2011;16(3):186-94.
2011: Jose A Karam; Christopher G Wood
The dark side of targeted therapy.
European urology 2011;59(4):541-2.
2011: Jose A Karam; Xiu-Ying Zhang; Pheroze Tamboli; Vitaly Margulis; Hua Wang; E Jason Abel; Stephen Hembree Culp; Christopher G Wood
Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma.
European urology 2011;59(4):619-28.
2011: Jose A Karam; Brian I Rini; Leticia Varella; Jorge A Garcia; Robert Dreicer; Toni K Choueiri; Eric Jonasch; Surena F Matin; Steven C Campbell; Christopher G Wood; Nizar M Tannir
Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.
The Journal of urology 2011;185(2):439-44.
2010: E Jason Abel; Stephen Hembree Culp; Surena F Matin; Pheroze Tamboli; Michael J Wallace; Eric Jonasch; Nizar M Tannir; Christopher G Wood
Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment.
The Journal of urology 2010;184(5):1877-81.
2010: Jose A Karam; Kamran Ahrar; Christopher G Wood; Eric Jonasch; Raghunandan Vikram; Claudio Romero; Nizar M Tannir; Surena F Matin
Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma.
The Journal of urology 2010;184(5):1882-7.
2010: E Jason Abel; Stephen Hembree Culp; Matthew Meissner; Surena F Matin; Pheroze Tamboli; Christopher G Wood
Identifying the risk of disease progression after surgery for localized renal cell carcinoma.
BJU international 2010;106(9):1277-83.
2010: M A T Hildebrandt; Jian Gu; Jie Lin; Y Ye; W Tan; Pheroze Tamboli; Christopher G Wood; Xifeng Wu
Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma.
Oncogene 2010;29(42):5724-8.
2010: Stephen Hembree Culp; Nizar M Tannir; E Jason Abel; Vitaly Margulis; Pheroze Tamboli; Surena F Matin; Christopher G Wood
Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?
Cancer 2010;116(14):3378-88.
2010: Surena F Matin; Vitaly Margulis; Ashish Kamat; Christopher G Wood; H Barton Grossman; Gordon A Brown; Colin P N Dinney; Randall Millikan; Arlene Siefker-Radtke
Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma.
Cancer 2010;116(13):3127-34.
2010: M Adam Childs; Christopher G Wood; Philippe E Spiess; Labib G Debiane; Mike Hernandez; Surena F Matin; Randall E Millikan; Arlene Siefker-Radtkie; Shellie M Scott; Louis L Pisters
Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy.
The Canadian journal of urology 2010;17(3):5184-9.
2010: S J Cooper; G C Blobe; N Hempel; S N Legrand; V Margulis; Laura Marlow; Derek Radisky; Han Tun; C A von Roemeling; Christopher G Wood; Kevin J Wu; H Zou; John A Copland
Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma.
Oncogene 2010;29(20):2905-15.
2010: Christopher G Wood
Editorial comment.
The Journal of urology 2010;183(4):1315-6; discussion 1316.
2010: Andrea A Chan; Christopher G Wood; Juan Caicedo; Mark F Munsell; Surena F Matin
Predictors of unilateral renal function after open and laparoscopic partial nephrectomy.
Urology 2010;75(2):295-302.
2009: Meng Chen; Yuanqing Ye; Hushan Yang; Pheroze Tamboli; Surena Matin; Nizar M Tannir; Christopher G Wood; Jian Gu; Xifeng Wu
Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
International journal of cancer. Journal international du cancer 2009;125(10):2342-8.
2009: Eric Jonasch; Christopher G Wood; Surena F Matin; Shi-Ming Tu; Lance C Pagliaro; Paul G Corn; Ana Aparicio; Pheroze Tamboli; Randall E Millikan; Xuemei Wang; John C Araujo; Wadih Arap; Nizar M Tannir
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4076-81.
2009: Scott E Delacroix; Christopher G Wood
The role of lymphadenectomy in renal cell carcinoma.
Current opinion in urology 2009;19(5):465-72.
2009: Christopher G Wood; Peter Mulders
Vitespen: a preclinical and clinical review.
Future oncology (London, England) 2009;5(6):763-74.
2009: E Jason Abel; Christopher G Wood
Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy.
Nature reviews. Urology 2009;6(7):375-83.
2009: Stephen Hembree Culp; Christopher G Wood
Words of wisdom. Re: Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomized, placebo- controlled phase III trial.
European urology 2009;55(6):1484-5.
2009: Christopher G Wood; Vitaly Margulis
Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease.
Cancer 2009;115(10 Suppl):2355-60.
2009: Raghunandan Vikram; Chaan S Ng; Pheroze Tamboli; Nizar M Tannir; Eric Jonasch; Surena F Matin; Christopher G Wood; Carl M Sandler
Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease.
Radiographics : a review publication of the Radiological Society of North America, Inc 2009;29(3):741-54; discussion 755-7.
2009: Vitaly Margulis; Michelle McDonald; Pheroze Tamboli; David A Swanson; Christopher G Wood
Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
The Journal of urology 2009;181(5):2044-51.
2009: John W Davis; David W Chang; Pierre Chevray; Run Wang; Yu Shen; Sijin Wen; Curtis A Pettaway; Louis L Pisters; David A Swanson; Lydia T Madsen; Nelda Huber; Patricia Troncoso; R Joseph Babaian; Christopher G Wood
Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer.
European urology 2009;55(5):1135-43.
2009: Vitaly Margulis; Shahrokh F Shariat; Surena F Matin; Ashish M Kamat; Richard Zigeuner; Eiji Kikuchi; Yair Lotan; Alon Z Weizer; Jay D Raman; Christopher G Wood
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Cancer 2009;115(6):1224-33.
2009: Robert S Svatek; Philippe E Spiess; Debasish Sundi; Shi-Ming Tu; Nizar M Tannir; Gordon A Brown; Ashish M Kamat; Christopher G Wood; Louis L Pisters
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.
Cancer 2009;115(6):1310-7.
2009: Dimitra Tsavachidou; Timothy J McDonnell; Sijin Wen; Xuemei Wang; Funda Vakar-Lopez; Louis L Pisters; Curtis A Pettaway; Christopher G Wood; Kim-Anh Do; Peter F Thall; Clifton Stephens; Eleni Efstathiou; Robert Taylor; David G Menter; Patricia Troncoso; Scott M Lippman; Christopher J Logothetis; Jeri Kim
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.
Journal of the National Cancer Institute 2009;101(5):306-20.
2009: Jessica Clague; Jie Lin; Adrian Cassidy; Surena Matin; Nizar M Tannir; Pheroze Tamboli; Christopher G Wood; Xifeng Wu
Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(3):801-7.
2009: Stephen Hembree Culp; Christopher G Wood
Should patients undergoing surgery for renal cell carcinoma have a lymph node dissection?
Nature clinical practice. Urology 2009;6(3):126-7.
2009: Wassim Kassouf; Robert Siemens; Christopher Morash; Louis Lacombe; Michael Jewett; Larry Goldenberg; Joseph Chin; Michael Chetner; Christopher G Wood; Simon Tanguay; Armen G Aprikian
Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2009;3(1):73-6.
2009: Vitaly Margulis; Surena F Matin; Nizar M Tannir; Pheroze Tamboli; Yu Shen; Marisa Lozano; David A Swanson; Eric Jonasch; Christopher G Wood
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma.
Urology 2009;73(2):337-41.
2009: Jinhee Kim; Eric Jonasch; Angela Alexander; Johnny D. Short; Shengli Cai; Sijin Wen; Dimitra Tsavachidou; Pheroze Tamboli; Bogdan A Czerniak; Kim-Anh Do; Kevin J Wu; Laura A Marlow; Christopher G Wood; John A Copland; Cheryl Lyn Walker
Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):81-90.
2009: Vitaly Margulis; Christopher G Wood
Pre-surgical targeted molecular therapy in renal cell carcinoma.
BJU international 2009;103(2):150-3.
2008: Yohei Horikawa; Christopher G Wood; Hushan Yang; Hua Zhao; Yuanqing Ye; Jian Gu; Jie Lin; Tomonori Habuchi; Xifeng Wu
Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7956-62.
2008: Ezogelin Oflazoglu; Ivan J Stone; Kristine Gordon; Christopher G Wood; Elizabeth A Repasky; Iqbal Grewal; Che-Leung Law; Hans-Peter Gerber
Potent anticarcinoma activity of the humanized anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linker.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(19):6171-80.
2008: Chaan S Ng; Christopher G Wood; Paul M Silverman; Nizar M Tannir; Pheroze Tamboli; Carl M Sandler
Renal cell carcinoma: diagnosis, staging, and surveillance.
AJR. American journal of roentgenology 2008;191(4):1220-32.
2008: Vitaly Margulis; Tapati Maity; Xiu-Ying Zhang; Simon J Cooper; John A Copland; Christopher G Wood
Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathway.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5722-30.
2008: Vitaly Margulis; Christopher G Wood
Is patient performance status always an accurate surrogate for predicting tumor biology in patients with metastatic renal cancer?
Cancer 2008;113(6):1282-3.
2008: Vitaly Margulis; Christopher G Wood
The role of lymph node dissection in renal cell carcinoma: the pendulum swings back.
Cancer journal (Sudbury, Mass.) 2008;14(5):308-14.
2008: Rajul Jain; Paul Mathew; Christopher G Wood; Nizar M Tannir
Sunitinib-induced acute hemolysis without hypertension: a case report.
Clinical genitourinary cancer 2008;6(2):122-3.
2008: Vitaly Margulis; Jie Lin; Hushan Yang; Wei Wang; Christopher G Wood; Xifeng Wu
Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(9):2366-73.
2008: Vitaly Margulis; Surena F Matin; Christopher G Wood
Cytoreductive nephrectomy in metastatic renal cell carcinoma.
Current opinion in urology 2008;18(5):474-80.
2008: Surena F Matin; Kamran Ahrar; Christopher G Wood; Molly Daniels; Eric Jonasch
Patterns of intervention for renal lesions in von Hippel-Lindau disease.
BJU international 2008;102(8):940-5.
2008: Vitaly Margulis; Christopher G Wood
Cytoreductive nephrectomy in the era of targeted molecular agents: is it time to consider presurgical systemic therapy?
European urology 2008;54(3):489-92.
2008: Jinliang Xing; Meng Chen; Christopher G Wood; Jie Lin; Margaret R Spitz; Jianzhong Ma; Christopher I Amos; Peter G Shields; Neal L Benowitz; Jian Gu; Mariza de Andrade; Gary E Swan; Xifeng Wu
Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma.
Journal of the National Cancer Institute 2008;100(15):1104-12.
2008: Vitaly Margulis; Surena F Matin; Nizar M Tannir; Pheroze Tamboli; David A Swanson; Eric Jonasch; Christopher G Wood
Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
The Journal of urology 2008;180(1):94-8.
2008: Yimin Zhu; Yohei Horikawa; Hushan Yang; Christopher G Wood; Tomonori Habuchi; Xifeng Wu
BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk.
The Journal of urology 2008;179(6):2416-21.
2008: Vitaly Margulis; Christopher G Wood; Eric Jonasch; Surena F Matin
Current status of debulking nephrectomy in the era of tyrosine kinase inhibitors.
Current oncology reports 2008;10(3):253-8.
2008: Vitaly Margulis; Pheroze Tamboli; Surena F Matin; David A Swanson; Christopher G Wood
Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
Cancer 2008;112(7):1480-8.
2008: Christopher G Wood
Adjuvant approaches to renal cell carcinoma.
Clinical advances in hematology & oncology : H&O 2008;6(1):19-21.
2008: James Booth; Surena F Matin; Kamran Ahrar; Pheroze Tamboli; Christopher G Wood
Contemporary strategies for treating nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques.
Urologic oncology 2008;26(1):37-42.
2007: Philippe E Spiess; Nizar M Tannir; Shi-Ming Tu; Gordon A Brown; Ping Liu; Ashish M Kamat; Christopher G Wood; James G Evans; Louis L Pisters
Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?
Cancer 2007;110(12):2700-8.
2007: Vitaly Margulis; Pheroze Tamboli; Kenneth M Jacobsohn; David A Swanson; Christopher G Wood
Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
BJU international 2007;100(6):1235-9.
2007: Vitaly Margulis; Pheroze Tamboli; Surena F Matin; Matthew Meisner; David A Swanson; Christopher G Wood
Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
The Journal of urology 2007;178(5):1878-82.
2007: Wassim Kassouf; Ricardo Sanchez-Ortiz; Pheroze Tamboli; Nizar M Tannir; Eric Jonasch; Madhur M Merchant; Surena F Matin; David A Swanson; Christopher G Wood
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
The Journal of urology 2007;178(5):1896-900.
2007: Lina Shao; Christopher G Wood; Di Zhang; Nizar M Tannir; Surena F Matin; Colin P N Dinney; Xifeng Wu
Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer.
The Journal of urology 2007;178(4 Pt 1):1492-6.
2007: Michelle L Gumz; Hongzhi Zou; Pamela A Kreinest; April C Childs; Leandra S Belmonte; Shauna N LeGrand; Kevin J Wu; Bruce A Luxon; Mala Sinha; Alexander S Parker; Luzhe Sun; David A Ahlquist; Christopher G Wood; John A Copland
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(16):4740-9.
2007: Xin Lin; Christopher G Wood; Lina Shao; Maosheng Huang; Hushan Yang; Colin P N Dinney; Xifeng Wu
Risk assessment of renal cell carcinoma using alkaline comet assay.
Cancer 2007;110(2):282-8.
2007: Vitaly Margulis; Christopher G Wood
Update on staging controversies for locally advanced renal cell carcinoma.
Expert review of anticancer therapy 2007;7(7):909-14.
2007: Peter C Black; Karen Basen-Engquist; Xuemei Wang; Richard J Swartz; Teresa Eddings; Surena F Matin; David Swanson; Christopher G Wood; Louis L Pisters; R Joseph Babaian; Patricia Troncoso; Curtis A Pettaway
A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial.
BJU international 2007;100(1):63-9.
2007: Vitaly Margulis; Pheroze Tamboli; Surena F Matin; Matthew Meisner; David A Swanson; Christopher G Wood
Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
Cancer 2007;109(12):2439-44.
2007: Christopher J Gannon; Jonathan S Zager; George J Chang; Barry W Feig; Christopher G Wood; John M Skibber; Miguel A Rodriguez-Bigas
Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Annals of surgical oncology 2007;14(6):1870-7.
2007: Vitaly Margulis; Ricardo F Sánchez-Ortiz; Pheroze Tamboli; Daniel D Cohen; David A Swanson; Christopher G Wood
Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management.
Cancer 2007;109(10):2025-30.
2007: Wassim Kassouf; Ricardo Sanchez-Ortiz; Pheroze Tamboli; Eric Jonasch; Madhur M Merchant; Philippe E Spiess; Christopher G Wood
Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
Urology 2007;69(5):835-8.
2007: Kenneth M Jacobsohn; Kamran Ahrar; Christopher G Wood; Surena F Matin
Is radiofrequency ablation safe for solitary kidneys?
Urology 2007;69(5):819-23; discussion 823.
2007: A Karim Kader; Pheroze Tamboli; Tony Luongo; Surena F Matin; Kayla Bell; Eric Jonasch; David A Swanson; Christopher G Wood
Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience.
The Journal of urology 2007;177(3):855-60; discussion 860-1.
2007: Christopher G Wood
Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(2 Pt 2):697s-702s.
2006: Gordon A Brown; J Erik Busby; Christopher G Wood; Louis L Pisters; Colin P N Dinney; David A Swanson; H Barton Grossman; Curtis A Pettaway; Mark F Munsell; Ashish M Kamat; Surena F Matin
Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
BJU international 2006;98(6):1176-80.
2006: Surena F Matin; Nadeem Dhanani; Mirelis Acosta; Christopher G Wood
Conventional and hand-assisted laparoscopic radical nephrectomy: Comparative analysis of 271 cases.
Journal of endourology / Endourological Society 2006;20(11):891-4.
2006: Kenneth M Jacobsohn; Christopher G Wood
Adjuvant therapy for renal cell carcinoma.
Seminars in oncology 2006;33(5):576-82.
2006: James G Evans; Philippe E Spiess; Ashish M Kamat; Christopher G Wood; Mike Hernandez; Curtis A Pettaway; Colin P N Dinney; Louis L Pisters
Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience.
The Journal of urology 2006;176(4 Pt 1):1463-7.
2006: Surena F Matin; Lydia T Madsen; Christopher G Wood
Laparoscopic cytoreductive nephrectomy: the M. D. Anderson Cancer Center experience.
Urology 2006;68(3):528-32.
2006: Galen E Howard; Christopher G Wood
Staging refinements in renal cell carcinoma.
Current opinion in urology 2006;16(5):317-20.
2006: Steven E Canfield; Ashish M Kamat; Ricardo F Sánchez-Ortiz; Michelle A Detry; David A Swanson; Christopher G Wood
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
The Journal of urology 2006;175(3 Pt 1):864-9.
2006: Che-Leung Law; Kristine A Gordon; Brian E Toki; Andrew K Yamane; Michelle A Hering; Charles G Cerveny; Joseph Petroziello; Maureen C Ryan; Leia Smith; Ronald Simon; Guido Sauter; Ezogelin Oflazoglu; Svetlana O Doronina; Damon L Meyer; Joseph A Francisco; Paul Carter; Peter D Senter; John A Copland; Christopher G Wood; Alan F Wahl
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.
Cancer research 2006;66(4):2328-37.
2005: Chandra Bartholomeusz; Hiroaki Itamochi; Linda X H Yuan; Francisco J Esteva; Christopher G Wood; Naoki Terakawa; Mien-Chie Hung; Naoto T Ueno
Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model.
Cancer research 2005;65(18):8406-13.
2005: Jeri Kim; Peiyu Sun; Ying-Wai Lam; Patricia Troncoso; Anita L Sabichi; Richard J Babaian; Louis L Pisters; Curtis A Pettaway; Christopher G Wood; Scott M Lippman; Timothy J McDonnell; Ronald Lieberman; Christopher Logothetis; Shuk-Mei Ho
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(7):1697-702.
2005: Kamran Ahrar; Surena F Matin; Christopher G Wood; Michael J Wallace; Sanjay Gupta; David C Madoff; Sujaya Rao; Nizar M Tannir; Eric Jonasch; Louis L Pisters; Marc A Rozner; Debra L Kennamer; Marshall E Hicks
Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.
Journal of vascular and interventional radiology : JVIR 2005;16(5):679-88.
2005: Daniel D Cohen; Surena F Matin; Jordan R Steinberg; Robin Zagone; Christopher G Wood
Evaluation of the intact specimen after laparoscopic radical nephrectomy for clinically localized renal cell carcinoma identifies a subset of patients at increased risk for recurrence.
The Journal of urology 2005;173(5):1487-90; discussion 1490-1.
2005: Jean-Jacques Patard; Emmanuelle Leray; Nathalie Rioux-Leclercq; Luca Cindolo; Vincenzo Ficarra; Amnon Zisman; Alexandre de la Taille; Jacques Tostain; Walter Artibani; Claude C Abbou; Bernard Lobel; François Guillé; Dominique K Chopin; Peter F A Mulders; Christopher G Wood; David A Swanson; Robert A Figlin; Arie S Belldegrun; Allan J Pantuck
Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2763-71.
2004: Reena B Wyatt; Ricardo F Sánchez-Ortiz; Christopher G Wood; Edilberto Ramirez; Christopher Logothetis; Curtis A Pettaway
Prognostic factors for survival among Caucasian, African-American and Hispanic men with androgen-independent prostate cancer.
Journal of the National Medical Association 2004;96(12):1587-93.
2004: Ricardo F Sánchez-Ortiz; Lydia T Madsen; Carlos Bermejo; Sijin Wen; Yu Shen; David A Swanson; Christopher G Wood
A renal mass in the setting of a nonrenal malignancy: When is a renal tumor biopsy appropriate?
Cancer 2004;101(10):2195-201.
2004: Jean-Jacques Patard; Hyung L Kim; John S Lam; Frederick J Dorey; Allan J Pantuck; Amnon Zisman; Vincenzo Ficarra; Ken-Ryu Han; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Walter Artibani; Colin P N Dinney; Christopher G Wood; David A Swanson; Claude C Abbou; Bernard Lobel; Peter F A Mulders; Dominique K Chopin; Robert A Figlin; Arie S Belldegrun
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(16):3316-22.
2004: Ricardo F Sánchez-Ortiz; Charles J Rosser; Lydia T Madsen; David A Swanson; Christopher G Wood
Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma.
The Journal of urology 2004;171(6 Pt 1):2160-5.
2004: Louis L Pisters; Curtis A Pettaway; Patricia Troncoso; Timothy J McDonnell; L Clifton Stephens; Christopher G Wood; Kim-Anh Do; Shawn Brisbay; Xuemei Wang; Elizabeth A Hossan; Robert B Evans; Cindy Soto; Marc G Jacobson; Karen Parker; James A Merritt; Mitchell S Steiner; Christopher J Logothetis
Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2587-93.
2004: Marco A Arap; Johanna Lahdenranta; Amin Hajitou; Frank C Marini; Christopher G Wood; Kenneth C Wright; Juan Fueyo; Wadih Arap; Renata Pasqualini
Model of unidirectional transluminal gene transfer.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(2):305-10.
2004: Ricardo F Sánchez-Ortiz; Lydia T Madsen; David A Swanson; Steven E Canfield; Christopher G Wood
Closed suction or penrose drainage after partial nephrectomy: does it matter?
The Journal of urology 2004;171(1):244-6.
2003: Ken-Ryu Han; Ivar Bleumer; Allan J Pantuck; Hyung L Kim; Frederick J Dorey; Nicolette K Janzen; Amnon Zisman; Colin P N Dinney; Christopher G Wood; David A Swanson; Jonathan W Said; Robert A Figlin; Peter F A Mulders; Arie S Belldegrun
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.
The Journal of urology 2003;170(6 Pt 1):2221-4.
2003: John A Copland; Bruce A Luxon; Laila Ajani; Tapati Maity; Erica Campagnaro; Huiping Guo; Shauna N LeGrand; Pheroze Tamboli; Christopher G Wood
Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
Oncogene 2003;22(39):8053-62.
2003: Paul Sweeney; Christopher G Wood; Louis L Pisters; Joel W Slaton; Ara A Vaporciyan; Mark F Munsell; Scott Carpenter; Joe B Putnam; Stephen G Swisher; Garrett Walsh; David Swanson; Colin P N Dinney
Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi.
Urologic oncology 2003;21(5):327-33.
2003: Christopher G Wood
The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma.
The Urologic clinics of North America 2003;30(3):581-8.
2003: Ricardo F Sánchez-Ortiz; Nizar M Tannir; Kamran Ahrar; Christopher G Wood
Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine?
The Journal of urology 2003;170(1):178-9.
2003: Paul Sweeney; Randall Millikan; S Machele Donat; Christopher G Wood; Arlene Siefker Radtke; Curtis A Pettaway; H Barton Grossman; Colin P N Dinney; David A Swanson; Louis L Pisters
Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?
The Journal of urology 2003;169(6):2113-7.
2003: Peter U Ardelt; Christopher G Wood; Limor Chen; Paul J Mintz; Catherine A Moya; Marco A Arap; Kenneth C Wright; Renata Pasqualini; Wadih Arap
Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands.
The Journal of urology 2003;169(4):1535-40.
2003: Wade J Sexton; Christopher G Wood; Richard Kim; Louis L Pisters
Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
The Journal of urology 2003;169(4):1353-6.
2003: David W Chang; Christopher G Wood; Stephen S Kroll; Adel A Youssef; R Joseph Babaian
Cavernous nerve reconstruction to preserve erectile function following non-nerve-sparing radical retropubic prostatectomy: a prospective study.
Plastic and reconstructive surgery 2003;111(3):1174-81.
2003: John A Copland; Peter Davies; Gregory L Shipley; Christopher G Wood; Bruce A Luxon; Randall J Urban
The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside.
Recent progress in hormone research 2003;58():25-53.
2002: David C Madoff; Barry D Toombs; Mark D Skolkin; Diane C Bodurka; Susan C Modesitt; Christopher G Wood; Marshall E Hicks
Endovascular management of ureteral-iliac artery fistulae with Wallgraft endoprostheses.
Gynecologic oncology 2002;85(1):212-7.
2001: Keji Inoue; Christopher G Wood; Joel W Slaton; Takashi Karashima; Paul Sweeney; Colin P N Dinney
Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8.
Oncology reports 2001;8(5):955-64.
2001: Jun Yang; Karim Fizazi; Sara Peleg; Charles R Sikes; A Kevin Raymond; N Jamal; Min Hu; Matilde Olive; Luis A. Martinez; Christopher G Wood; Christopher J Logothetis; Gerard Karsenty; Nora M Navone
Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Cancer research 2001;61(14):5652-9.
2000: Keji Inoue; Paul Perrotte; Christopher G Wood; Joel W Slaton; Paul Sweeney; Colin P N Dinney
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4422-31.
1999: Weiping Luo; M Tapolsky; Karen Earley; Christopher G Wood; D R Wilson; C J Logothetis; Sue-Hwa Lin
Tumor-suppressive activity of CD66a in prostate cancer.
Cancer gene therapy 1999;6(4):313-21.
1997: Weiping Luo; Christopher G Wood; Karen Earley; Mien-Chie Hung; Sue-Hwa Lin
Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains.
Oncogene 1997;14(14):1697-704.